Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanru Zhao

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Frontiers in Genetics|December 17, 2020
The Cell Type-Specific Functions of miR-21 in Cardiovascular DiseasesBeibei Dai, Feng Wang, Xiang Nie, et al.
Molecular Therapy. Nucleic Acids|October 11, 2021
miR-320a induces pancreatic β cells dysfunction in diabetes by inhibiting MafFHengzhi Du, Zhongwei Yin, Yanru Zhao, et al.
Circulation Research|October 23, 2019
Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the HeartHuaping Li, Jiahui Fan, Yanru Zhao, et al.
Scientific Reports|July 2, 2025
The function of PCSK9 in doxorubicin-induced cardiotoxicity and its underlying mechanismShuai Shi, Zhihui Qin, Chang Liu, et al.
Brain Research Bulletin|May 15, 2012
Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neuronsWenjuan Shen, Renbin Qi, Jing Zhang, et al.
Science China. Life Sciences|May 29, 2024
Fibroblast-localized lncRNA CFIRL promotes cardiac fibrosis and dysfunction in dilated cardiomyopathyShuai Yuan, Xudong Zhang, Jiabing Zhan, et al.
Aging|May 19, 2019
MiR-320a induces diabetic nephropathy via inhibiting MafBMengying He, Jin Wang, Zhongwei Yin, et al.
Aging|December 15, 2022
Correction for: MiR-320a induces diabetic nephropathy via inhibiting MafBMengying He, Jin Wang, Zhongwei Yin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2024
Nuclear AGO2 promotes myocardial remodeling by activating ANKRD1 transcription in failing heartsRong Xie, Shuai Yuan, Guo Hu, et al.
Cells|November 11, 2022
KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 SignallingFangfang Li, Jingfeng Peng, Hui Feng, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Frontiers in Genetics|December 17, 2020
The Cell Type-Specific Functions of miR-21 in Cardiovascular DiseasesBeibei Dai, Feng Wang, Xiang Nie, et al.
Molecular Therapy. Nucleic Acids|October 11, 2021
miR-320a induces pancreatic β cells dysfunction in diabetes by inhibiting MafFHengzhi Du, Zhongwei Yin, Yanru Zhao, et al.
Circulation Research|October 23, 2019
Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the HeartHuaping Li, Jiahui Fan, Yanru Zhao, et al.
Scientific Reports|July 2, 2025
The function of PCSK9 in doxorubicin-induced cardiotoxicity and its underlying mechanismShuai Shi, Zhihui Qin, Chang Liu, et al.
Brain Research Bulletin|May 15, 2012
Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neuronsWenjuan Shen, Renbin Qi, Jing Zhang, et al.
Science China. Life Sciences|May 29, 2024
Fibroblast-localized lncRNA CFIRL promotes cardiac fibrosis and dysfunction in dilated cardiomyopathyShuai Yuan, Xudong Zhang, Jiabing Zhan, et al.
Aging|May 19, 2019
MiR-320a induces diabetic nephropathy via inhibiting MafBMengying He, Jin Wang, Zhongwei Yin, et al.
Aging|December 15, 2022
Correction for: MiR-320a induces diabetic nephropathy via inhibiting MafBMengying He, Jin Wang, Zhongwei Yin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2024
Nuclear AGO2 promotes myocardial remodeling by activating ANKRD1 transcription in failing heartsRong Xie, Shuai Yuan, Guo Hu, et al.
Cells|November 11, 2022
KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 SignallingFangfang Li, Jingfeng Peng, Hui Feng, et al.
Pageof 10